Skip to content

Thermal Imaging in Neonates: A Feasibility Study in Healthy Babies and Babies With Suspected TTN

Thermal Imaging in Neonates: a Feasibility Study in Healthy Babies and Babies With Suspected Transient Tachypnea of the Newborn (TTN)

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02570828
Enrollment
25
Registered
2015-10-07
Start date
2015-10-31
Completion date
2016-07-31
Last updated
2017-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thermal Imaging, Neonatal Pneumonia, Tachypnea

Keywords

healthy neonate, tachypnea, thermal imaging, pneumonia

Brief summary

This is a study to evaluate thermal imaging as a technology to monitor the normal clearing of amniotic fluid from healthy newborns and newborns suspected of having a condition called transient tachypnea of the newborn, or TTN. Thermal images are taken using an imaging device that attaches to an iPhone. This device, commercially known as FLIR ONE, creates a non-identifiable image based on the heat pattern of an object. In this case, the object is a child's chest and back. It does not emit any radiation like an x-ray does.

Interventions

FLIR ONE attachment to an iPhone

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 3 Days
Healthy volunteers
Yes

Inclusion criteria

(healthy and suspected TTN babies): * Full term (greater than or equal to 37 weeks gestation) * less than 3 days old * born via normal vaginal delivery Inclusion Criteria (only for suspected TTN babies): * neonatologist assesses baby as possibly having TTN * chest x-ray done as part of evaluation for TTN * no other significant co-morbid conditions present

Exclusion criteria

* parents do not consent to have baby participate

Design outcomes

Primary

MeasureTime frameDescription
asymmetric heat distributionwithin the first 3 days of lifethermal imaging will be used to capture asymmetric heat distribution across lung fields

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026